SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059108
Filing Date
2024-05-14
Accepted
2024-05-14 08:13:53
Documents
64
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q iobt-20240331.htm   iXBRL 10-Q 1690071
2 EX-31.1 iobt-ex31_1.htm EX-31.1 15878
3 EX-31.2 iobt-ex31_2.htm EX-31.2 15752
4 EX-32.1 iobt-ex32_1.htm EX-32.1 8890
5 EX-32.2 iobt-ex32_2.htm EX-32.2 8767
6 GRAPHIC img134946518_0.jpg GRAPHIC 85197
7 GRAPHIC img134946518_1.jpg GRAPHIC 118634
  Complete submission text file 0000950170-24-059108.txt   6225639

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT iobt-20240331.xsd EX-101.SCH 797929
67 EXTRACTED XBRL INSTANCE DOCUMENT iobt-20240331_htm.xml XML 702414
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41008 | Film No.: 24941541
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)